Surmodics to Present at Jefferies 2018 Global Healthcare Conference
Webcast is Live on Friday, June 8, at 11:30 a.m. (ET)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--May 30, 2018--
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in
vitro diagnostic technologies to the healthcare industry, today
announced that Gary Maharaj, president and chief executive officer, and
Tim Arens, interim vice president of finance and chief financial
officer, will make a presentation to the investment community at the
Jefferies 2018 Global Healthcare Conference in New York City on Friday,
June 8, 2018, at 11:30 a.m. ET (10:30 a.m. CT).
A live audio webcast of the presentation will be available by going to
the investor relations portion of the Company’s website at www.surmodics.com
and clicking on the webcast icon. The webcast will be archived on the
Company’s website for 90 days following the live presentation.
About Surmodics, Inc.
Surmodics is the global leader in surface modification technologies for
intravascular medical devices and a leading provider of chemical
components for in vitro diagnostic (IVD) immunoassay tests
and microarrays. Surmodics is pursuing highly differentiated
whole-product solutions that are designed to address unmet clinical
needs for its medical device customers and engineered to the most
demanding requirements. This key growth strategy leverages the
combination of the Company’s expertise in proprietary surface
technologies, along with enhanced device design, development and
manufacturing capabilities. The Company mission remains to improve the
detection and treatment of disease. Surmodics is headquartered in Eden
Prairie, Minnesota. For more information, visit www.surmodics.com. The
content of Surmodics’ website is not part of this press release or part
of any filings that the company makes with the SEC.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180530005325/en/
Source: Surmodics, Inc.
Tim Arens, 952-500-7000